These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8400920

  • 1. S-ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats.
    Zeng QQ, Jee WS, Ke HZ, Wechter WJ.
    Bone Miner; 1993 Jun; 21(3):203-18. PubMed ID: 8400920
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ, Jee WS, Zeng QQ, Li M, Lin BY.
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [Abstract] [Full Text] [Related]

  • 3. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
    Iwamoto J, Seki A, Takeda T, Yamada H, Sato Y, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):191-7. PubMed ID: 17874822
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WS, Thompson DD.
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [Abstract] [Full Text] [Related]

  • 5. Time responses of cancellous and cortical bones to sciatic neurectomy in growing female rats.
    Zeng QQ, Jee WS, Bigornia AE, King JG, D'Souza SM, Li XJ, Ma YF, Wechter WJ.
    Bone; 1996 Jul; 19(1):13-21. PubMed ID: 8830982
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ, Qi H, Chidsey-Frink KL, Crawford DT, Thompson DD.
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [Abstract] [Full Text] [Related]

  • 10. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS, Schmidt IU, Evans GL, Turner RT.
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [Abstract] [Full Text] [Related]

  • 11. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD.
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [Abstract] [Full Text] [Related]

  • 12. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
    Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
    [Abstract] [Full Text] [Related]

  • 13. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF, Jee WS, Ke HZ, Lin BY, Liang XG, Li M, Yamamoto N.
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [Abstract] [Full Text] [Related]

  • 14. Adaptation of cancellous bone to aging and immobilization in growing rats.
    Chen MM, Jee WS, Ke HZ, Lin BY, Li QN, Li XJ.
    Anat Rec; 1992 Nov; 234(3):317-34. PubMed ID: 1443661
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of combined administration of alendronate and alfacalcidol on cancellous bone mass of the tibia in orchidectomized rats: a bone histomorphometry study.
    Iwamoto J, Takeda T, Matsumoto H, Sato Y, K Yeh J.
    J Nutr Sci Vitaminol (Tokyo); 2008 Feb; 54(1):11-7. PubMed ID: 18388402
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J, Takeda T, Sato Y, Shen CL, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [Abstract] [Full Text] [Related]

  • 17. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ.
    Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
    Ke HZ, Li M, Jee WS.
    Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study.
    Iwamoto J, Takeda T, Sato Y, Yeh JK.
    J Bone Miner Metab; 2007 Oct; 25(1):46-53. PubMed ID: 17187193
    [Abstract] [Full Text] [Related]

  • 20. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
    Iwamoto J, Yeh JK, Takeda T.
    J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.